ImmuCell Other Current Assets 2010-2025 | ICCC
ImmuCell other current assets from 2010 to 2025. Other current assets can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
| ImmuCell Annual Other Current Assets (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $0 |
| 2021 | $0 |
| 2020 | $0 |
| 2019 | $0 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $0 |
| 2015 | $0 |
| 2014 | $0 |
| 2013 | $0 |
| 2012 | $0 |
| 2011 | $0 |
| 2010 | $0 |
| 2009 | $0 |
| ImmuCell Quarterly Other Current Assets (Millions of US $) |
|
|---|---|
| 2025-03-31 | |
| 2024-12-31 | |
| 2024-09-30 | |
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | $1 |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| 2015-03-31 | |
| 2014-12-31 | |
| 2014-09-30 | |
| 2014-06-30 | |
| 2014-03-31 | |
| 2013-12-31 | |
| 2013-09-30 | |
| 2013-06-30 | |
| 2013-03-31 | |
| 2012-12-31 | |
| 2012-09-30 | |
| 2012-06-30 | |
| 2012-03-31 | |
| 2011-12-31 | |
| 2011-09-30 | $0 |
| 2011-06-30 | $0 |
| 2011-03-31 | $0 |
| 2010-12-31 | $0 |
| 2010-09-30 | $0 |
| 2010-06-30 | $0 |
| 2010-03-31 | $0 |
| 2009-12-31 | $0 |
| 2009-09-30 | $0 |
| 2009-06-30 | $1 |
| 2009-03-31 | $1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.060B | $0.026B |
| ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM, a human application of its milk-derived passive antibodytechnology for use as an alternative to antibiotics in the treatment and/or prevention of Clostridium difficile-associated diarrhea. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.035B | 26.74 |
| Boston Scientific (BSX) | United States | $152.087B | 36.27 |
| Stryker (SYK) | United States | $143.981B | 29.31 |
| EssilorLuxottica (ESLOY) | France | $137.519B | 0.00 |
| Medtronic (MDT) | Ireland | $118.029B | 16.74 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.517B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.032B | 24.56 |
| ResMed (RMD) | United States | $41.478B | 29.66 |
| GE HealthCare Technologies (GEHC) | United States | $33.973B | 15.97 |
| Agilent Technologies (A) | United States | $33.326B | 21.73 |
| Terumo (TRUMY) | Japan | $27.583B | 32.68 |
| Koninklijke Philips (PHG) | Netherlands | $25.989B | 17.19 |
| Insulet (PODD) | United States | $21.796B | 73.03 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.170B | 12.84 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.868B | 0.00 |
| Baxter (BAX) | United States | $12.317B | 9.52 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.240B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.436B | 27.31 |
| Lantheus Holdings (LNTH) | United States | $3.665B | 9.91 |
| Envista Holdings (NVST) | United States | $3.472B | 24.29 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.214B | 14.26 |
| Perrigo (PRGO) | Ireland | $3.174B | 7.93 |
| ICU Medical (ICUI) | United States | $2.723B | 18.54 |
| Haemonetics (HAE) | United States | $2.516B | 11.23 |
| LeMaitre Vascular (LMAT) | United States | $2.137B | 45.82 |
| Curaleaf Holdings (CURLF) | Canada | $1.824B | 0.00 |
| AtriCure (ATRC) | United States | $1.781B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.732B | 74.36 |
| QuidelOrtho (QDEL) | United States | $1.710B | 10.77 |
| AdaptHealth (AHCO) | United States | $1.287B | 18.35 |
| Phibro Animal Health (PAHC) | United States | $1.203B | 15.38 |
| BioLife Solutions (BLFS) | United States | $1.153B | 2406.00 |
| Acuren (TIC) | United States | $1.142B | 0.00 |
| Neogen (NEOG) | United States | $1.136B | 18.03 |
| Tilray Brands (TLRY) | Canada | $1.046B | 0.00 |
| InMode (INMD) | Israel | $0.899B | 8.32 |
| Valneva SE (VALN) | France | $0.800B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.772B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.685B | 0.00 |
| Surmodics (SRDX) | United States | $0.542B | 0.00 |
| ZimVie (ZIMV) | United States | $0.532B | 20.49 |
| SNDL (SNDL) | Canada | $0.531B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.511B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.465B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.439B | 15.10 |
| CeriBell (CBLL) | United States | $0.429B | 0.00 |
| Owens & Minor (OMI) | United States | $0.423B | 3.75 |
| Evolus (EOLS) | United States | $0.414B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.368B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.357B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.330B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.318B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.298B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.289B | 21.88 |
| Omeros (OMER) | United States | $0.258B | 0.00 |
| Cerus (CERS) | United States | $0.247B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.244B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.238B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.233B | 0.00 |
| Brainsway (BWAY) | Israel | $0.230B | 60.95 |
| Quanterix (QTRX) | United States | $0.221B | 0.00 |
| Organigram Global (OGI) | Canada | $0.213B | 0.00 |
| Exagen (XGN) | United States | $0.210B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.205B | 0.00 |
| High Tide (HITI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.187B | 15.40 |
| Biote (BTMD) | United States | $0.158B | 4.74 |
| FitLife Brands (FTLF) | United States | $0.158B | 19.40 |
| TriSalus Life Sciences (TLSI) | United States | $0.138B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.136B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.09 |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.067B | 0.00 |
| Safety Shot (SHOT) | United States | $0.054B | 0.00 |
| Zynex (ZYXI) | United States | $0.048B | 0.00 |
| Veru (VERU) | United States | $0.046B | 0.00 |
| Nephros (NEPH) | United States | $0.045B | 35.50 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.38 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Flora Growth (FLGC) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |